Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors

Summary

This first-in-human dose-escalation study is to characterize the safety, tolerability, pharmacokinetics and pharmacodynamics of LDE225 given orally on a daily dosing schedule in patients with advanced solid tumors.

Timeline

Start

2009-03

Primary completion

2013-07

Completion

2013-07

Drugs

Indications